Daniel V. Santi
Oprichter bij Prolynx LLC
Actieve functies van Daniel V. Santi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Prolynx LLC
 Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-01-2010 | - |
| Oprichter | 01-01-2010 | - | |
| President | 01-01-2010 | - |
Loopbaan van Daniel V. Santi
Eerdere bekende functies van Daniel V. Santi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Voorzitter | - | 14-02-2006 |
| Oprichter | - | 14-02-2006 | |
| President | - | 14-02-2006 | |
| The University of California, San Francisco | Corporate Officer/Principal | 01-01-1974 | 01-01-2001 |
Opleiding van Daniel V. Santi
| The State University of New York | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Founder | 2 |
| President | 2 |
| Doctorate Degree | 2 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Prolynx LLC
Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Commercial Services |
- Beurs
- Insiders
- Daniel V. Santi
- Ervaring
